Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGTX Meiragtx Holdings Plc

Market Closed 07-24 16:00:00 EDT

11.77

-0.33

-2.73%

盘后11.77

+0.000.00%

19:34 EDT

High12.33	Low11.69	Vol497.31K
Open12.13	D1 Closing12.10	Amplitude5.28%
Mkt Cap1.09B	Tradable Cap615.10M	Total Shares92.56M
T/O5.89M	T/O Rate0.95%	Tradable Shares52.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MGTX","market":"US","secType":"STK","nameCN":"Meiragtx Holdings Plc","latestPrice":11.77,"timestamp":1784923200000,"preClose":12.1,"halted":0,"volume":497312,"hourTrading":{"tag":"盘后","latestPrice":11.77,"preClose":11.77,"latestTime":"19:34 EDT","volume":24335,"amount":286422.95,"timestamp":1784936048800,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02727272727272728,"floatShares":52259600,"shares":92557200,"eps":-1.48811,"marketStatus":"Market Closed","change":-0.33,"latestTime":"07-24 16:00:00 EDT","open":12.13,"high":12.3287,"low":11.69,"amount":5891229.067616,"amplitude":0.052785,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.48811,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1528430400000,"exchange":"NASDAQ","adjPreClose":12.1,"preHourTrading":{"tag":"盘前","latestPrice":11.75,"preClose":12.1,"latestTime":"09:05 EDT","volume":240,"amount":2886.40032,"timestamp":1784898307763,"change":-0.35,"changeRate":-0.028926,"amplitude":0.080992},"postHourTrading":{"tag":"盘后","latestPrice":11.77,"preClose":11.77,"latestTime":"19:34 EDT","volume":24335,"amount":286422.95,"timestamp":1784936048800,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1772643148814343,"impliedVol":0.0952,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MGTX","defaultTab":"news","newsList":[{"id":"2653825217","title":"Meiragtx CFO, COO Richard Giroux Disposes of 56,000 Shares for $700,560","url":"https://stock-news.laohu8.com/highlight/detail?id=2653825217","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653825217?lang=en_us&edition=fundamental","pubTime":"2026-07-22 09:12","pubTimestamp":1784682774,"startTime":"0","endTime":"0","summary":"MeiraGTx CFO, COO Richard Giroux disposes of 56,000 shares for $700,560MeiraGTx: CFO and COO Richard Giroux sold 56,000 ordinary shares on July 21, 2026 at a weighted average price of $12.51.Giroux’s ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL9GQM8b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Meiragtx CFO, COO Richard Giroux Disposes of 56,000 Shares for $700,560","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650130387","title":"MeiraGTx Holdings (MGTX) Secures Oberland Funding, Is The Stock Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2650130387","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650130387?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:43","pubTimestamp":1783716230,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings (MGTX) is back in focus after securing a financing agreement with Oberland Capital that could provide up to $400 million, including a large non dilutive royalty component tied to future product revenues.\nSee our latest analysis for MeiraGTx Holdings.\nAt a latest share price of $13.94, MeiraGTx Holdings has seen a strong 30 day share price return of 51.36% and a 90 day share price return of 55.41%. The year to date share price return of 78.49% and 3 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/meiragtx-holdings-mgtx-secures-oberland-funding-is-the-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/meiragtx-holdings-mgtx-secures-oberland-funding-is-the-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650922177","title":"Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650922177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650922177?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:20","pubTimestamp":1783603216,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-meiragtx-holdings-mgtx-and-sensus-healthcare-srts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-meiragtx-holdings-mgtx-and-sensus-healthcare-srts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4082","BK4139","XBI","BK4585","XLV","MGTX","LABU","SRTS","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999224","title":"MeiraGTx Royalty Deal Strengthens Funding for Commercial Launch, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999224","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999224?lang=en_us&edition=fundamental","pubTime":"2026-07-08 23:35","pubTimestamp":1783524920,"startTime":"0","endTime":"0","summary":"MeiraGTx's  $400 million strategic financing agreement with Oberland Capital provides a meaningful source of non-dilutive capital to support the development and potential commercial launches of its XLRP and xerostomia programs, RBC Capital said in a Tuesday note.The brokerage said the royalty financing is only minimally accretive to its financial model but viewed the transaction positively because it strengthens MeiraGTx's cash position.RBC also said Oberland's willingness to provide at-risk synthetic royalty financing before any of the company's programs receive regulatory approval represents external validation of MeiraGTx's late-stage pipeline.According to the report, the agreement features a relatively low 1.95% royalty rate and a capped repayment structure, which compares favorably with similar royalty financing transactions in the biotechnology sector.RBC maintained its outperform rating on the stock and raised its price target to $26 from $25.MeiraGTx shares were down 6.2% in We","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649960381","title":"Meiragtx Holdings Price Target Maintained with a $20.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2649960381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649960381?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:27","pubTimestamp":1783506420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MGTX/analyst-ratings(END) Dow Jones NewswiresJuly 08, 2026 06:27 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649696723","title":"Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649696723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649696723?lang=en_us&edition=fundamental","pubTime":"2026-07-08 18:20","pubTimestamp":1783506022,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Meiragtx Holdings (MGTX) and Vera Therapeutics (VERA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-meiragtx-holdings-mgtx-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-meiragtx-holdings-mgtx-and-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","VERA","BK4139","LU0128526141.USD","LABU","LU0029874061.USD","LU2324357040.USD","XBI","XLV","BK4539","HCSG","BK4588","MGTX","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649395620","title":"Meiragtx Chief Scientific Officer, Ophthalmology Stuart Naylor Sells USD 410,811 in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649395620","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649395620?lang=en_us&edition=fundamental","pubTime":"2026-07-08 09:05","pubTimestamp":1783472734,"startTime":"0","endTime":"0","summary":"MeiraGTx Chief Scientific Officer, Ophthalmology Stuart Naylor sells USD 410,811 in sharesMeiraGTx reported open-market sales by Stuart Naylor, chief scientific officer, ophthalmology, on July 7, 2026","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLbtblbF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Meiragtx Chief Scientific Officer, Ophthalmology Stuart Naylor Sells USD 410,811 in Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649338934","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2649338934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649338934?lang=en_us&edition=fundamental","pubTime":"2026-07-08 01:36","pubTimestamp":1783445779,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  and Crinetics Pharmaceuticals  said late Monday they have reached an agreement for Vertex to buy Crinetics for $85 per share in cash. The deal has a total equity value of about $10 billion and is expected to close in Q3, the companies said.Shares of Crinetics almost doubled amid a surge in intraday trading volume to over 67.1 million from a daily average of roughly 1.30 million.MeiraGTx  has signed a deal under which Oberland Capital Management has agreed to invest up to $400 million in the company, including up to $375 million in non-dilutive capital for capped royalty payments on certain products and up to $25 million in equity, it said Tuesday.Shares jumped 8.2% following an increase in intraday trading volume to over 1.01 million from a daily average of about 987,000.Tvardi Therapeutics  said Tuesday its phase 1 study confirmed rapid prodrug conversion of TTI-109 to TTI-101, producing nearly identical plasma levels at molar-equivalent doses, and validating i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","MGTX","BK4588","LU0823416689.USD","LU2456880835.USD","IE0002141913.USD","IE0002270589.USD","IE00B2B36J28.USD","BBH","LU2362541273.HKD","LU0256863811.USD","LU1069344957.HKD","CRNX","LU0417517546.SGD","LU2236285917.USD","LU1585245621.USD","LU0234570918.USD","LU1093756325.SGD","IBB","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0432979614.USD","LU2462157665.USD","SG9999001176.SGD","VRTX","LU1674673428.USD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","IBBQ","BK4007","LU0889565916.HKD","BK4533","BIB","IDNA","SG9999001176.USD","PBE","IE00B19Z9Z06.USD","LU2324357040.USD","LU0320765992.SGD","LU1430594728.SGD","TVRD","IE00BJJMRZ35.SGD","BK4532","LU1035775433.USD","IE0009355771.USD","BK4567","LU0079474960.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982330","title":"Meiragtx Rises as Oberland Capital Commits up to $400 Mln for Late-stage Gene Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982330","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649982330?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:40","pubTimestamp":1783424433,"startTime":"0","endTime":"0","summary":"BUZZ-MeiraGTx rises as Oberland Capital commits up to $400 mln for late-stage gene therapies** Shares of gene therapy firm MeiraGTxMGTX.Orise 7.3% to $14.90 premarket** Co says it secured up to $400 mln from Oberland Capital to advance three late-stage experimental gene therapies** Funding includes up to $375 mln in non-dilutive financing tied to future sales royalties and up to $25 mln in equity investment** Co says it has already received $135 mln, including $125 mln for future royalties and $10 mln in equity** Additional $150 mln available upon positive trial data and regulatory approvals expected in 2027-2028** Oberland may provide another $100 mln for new products or business development and can buy an additional $15 mln in MeiraGTx shares, MGTX says** As of last close, stock was up ~75% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984027","title":"Meiragtx Shares up 3.5% Premarket After Co Announces $400 Mln Strategic Investment by Oberland Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984027?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:36","pubTimestamp":1783424173,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4390Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984010","title":"Meiragtx Holdings - Oberland Capital Has Right to Purchase Additional $15 Mln in Meiragtx Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649984010?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:30","pubTimestamp":1783423801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA4RXSBT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649847939","title":"Press Release: Meiragtx Announces $400 Million Strategic Investment by Oberland Capital to Support Development and Commercialization of Aav2-haqp1 and Botaretigene Sparoparvovec (bota-vec)","url":"https://stock-news.laohu8.com/highlight/detail?id=2649847939","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649847939?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:30","pubTimestamp":1783423800,"startTime":"0","endTime":"0","summary":"-- MeiraGTx to receive up to $375 million in non-dilutive cash and up to $25. -- Following regulatory approval, Oberland Capital to receive low. single-digit capped royalties on the net sales of each of AAV2-hAQP1 for. the treatment of grade 2/3 late radiation-induced xerostomia ,single-digit royalties on the included products, and a $10 million equity. to AAV2-hAQP1 positive data readouts from the Phase 2 AQUAx2 study in. -- An additional $50 million will be available at the Company's option tied","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Meiragtx Announces $400 Million Strategic Investment by Oberland Capital to Support Development and Commercialization of Aav2-haqp1 and Botaretigene Sparoparvovec (bota-vec)","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645939015","title":"Does MeiraGTx (MGTX) Revenue Slide And Lower Institutional Ownership Reframe Its Long-Term Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645939015","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645939015?lang=en_us&edition=fundamental","pubTime":"2026-06-22 02:18","pubTimestamp":1782065909,"startTime":"0","endTime":"0","summary":"In recent days, MeiraGTx Holdings reported a very large year-over-year drop in quarterly revenue alongside a double-digit decline in net profit, while key financial line items such as cash flow and operating profit remain undisclosed.\nAt the same time, institutional ownership fell quarter-over-quarter, with the largest institutional holder, Bill Nygren | OAKMX, sharply reducing its position, raising questions about shifting institutional confidence.\nNext, we’ll examine how this steep revenue...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/does-meiragtx-mgtx-revenue-slide-and-lower-institutional-own","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mgtx/meiragtx-holdings/news/does-meiragtx-mgtx-revenue-slide-and-lower-institutional-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640516669","title":"MeiraGTx publishes corporate deck outlining late-stage gene therapy pipeline, manufacturing platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2640516669","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640516669?lang=en_us&edition=fundamental","pubTime":"2026-06-04 23:43","pubTimestamp":1780587819,"startTime":"0","endTime":"0","summary":"MeiraGTx highlighted four late-stage gene therapy programs, led by AAV-AQP1 in pivotal Phase 2 for radiation-induced xerostomia with potential BLA filing early 2027.X-linked retinitis pigmentosa program completed Phase 3, described as BLA and MAA ready, with process performance qualification reported complete.AAV-GAD for Parkinson’s disease positioned as Phase 3 ready, with a potential BLA filing in 2028, supported by sham-controlled trial data.Ophthalmology collaboration with Eli Lilly outlined, including USD 75 million upfront cash, up to USD 135 million near-term AAV-AIPL1 milestones, royalties.Hologen AI transaction detailed, including USD 200 million upfront cash, a JV backed by USD 230 million committed capital to fund AAV-GAD through commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL8gp686:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636896816","title":"MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540","url":"https://stock-news.laohu8.com/highlight/detail?id=2636896816","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636896816?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:05","pubTimestamp":1779239156,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings reported President and CEO Alexandria Forbes sold 62,000 ordinary shares on May 19, 2026.The shares were sold at a weighted average price of USD 9.17.Forbes held 1,387,695 ordinary shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL9g6kHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $568,540","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635150084","title":"Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635150084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635150084?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:10","pubTimestamp":1778847007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Meiragtx Holdings (MGTX) and CalciMedica (CALC) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-meiragtx-holdings-mgtx-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-meiragtx-holdings-mgtx-calcimedica-calc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BLSG","XBI","LU0128526141.USD","BK4585","BK4139","BK4112","BK4581","BK4137","MGTX","LABU","LU0029874061.USD","BLSX","BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081692","title":"RBC Raises Price Target on MeiraGTx Holdings to $25 From $24, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081692","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081692?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:59","pubTimestamp":1778846382,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings (MGTX) has an average rating of buy and mean price target of $28, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MGTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778870","title":"MeiraGTx files Form 3 for Chief Development Officer Penny Renee Fleck","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778870","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635778870?lang=en_us&edition=fundamental","pubTime":"2026-05-15 09:01","pubTimestamp":1778806868,"startTime":"0","endTime":"0","summary":"MeiraGTx filed an initial Form 3 naming Penny Renee Fleck as chief development officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1BFSR5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635250377","title":"MeiraGTx grants CDO Penny Fleck 100,000 options, 100,000 RSUs as inducement award","url":"https://stock-news.laohu8.com/highlight/detail?id=2635250377","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635250377?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:31","pubTimestamp":1778790662,"startTime":"0","endTime":"0","summary":"MeiraGTx granted Chief Development Officer Penny Fleck inducement equity awards tied to her start date.Package includes non-qualified stock options for 100,000 ordinary shares at exercise price USD 9.97, with 25% vesting on first anniversary then monthly vesting over 36 months.Grant also includes 100,000 time-based RSUs, with 50% vesting on second anniversary then 25% on each of third and fourth anniversaries.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL6BbcZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","NDAQ","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","IE00B64PRP62.GBP","MGTX","SG9999014021.USD","LU0314104364.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4585","BK4112","SG9999014039.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635257777","title":"MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635257777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635257777?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA59TZ8Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MGTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meiragtx.com","stockEarnings":[{"period":"1week","weight":-0.0539},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.2752},{"period":"6month","weight":0.4531},{"period":"1year","weight":0.4164},{"period":"ytd","weight":0.4805}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.012037},{"month":2,"riseRate":0.5,"avgChangeRate":0.0333},{"month":3,"riseRate":0.25,"avgChangeRate":-0.052743},{"month":4,"riseRate":0.75,"avgChangeRate":-0.013966},{"month":5,"riseRate":0.625,"avgChangeRate":0.013491},{"month":6,"riseRate":0.5,"avgChangeRate":0.058638},{"month":7,"riseRate":0.555556,"avgChangeRate":0.008405},{"month":8,"riseRate":0.375,"avgChangeRate":-0.045501},{"month":9,"riseRate":0.75,"avgChangeRate":-0.003363},{"month":10,"riseRate":0.375,"avgChangeRate":0.087707},{"month":11,"riseRate":0.625,"avgChangeRate":0.051284},{"month":12,"riseRate":0.625,"avgChangeRate":0.053515}],"exchange":"NASDAQ","name":"Meiragtx Holdings Plc","nameEN":"Meiragtx Holdings Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Meiragtx Holdings Plc,MGTX,Meiragtx Holdings Plc股票,Meiragtx Holdings Plc股票老虎,Meiragtx Holdings Plc股票老虎国际,Meiragtx Holdings Plc行情,Meiragtx Holdings Plc股票行情,Meiragtx Holdings Plc股价,Meiragtx Holdings Plc股市,Meiragtx Holdings Plc股票价格,Meiragtx Holdings Plc股票交易,Meiragtx Holdings Plc股票购买,Meiragtx Holdings Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}